Feds Slam Regeneron's Attempt To Duck Kickback Suit

Law360 (September 22, 2020, 5:44 PM EDT) -- The federal government has urged a Massachusetts federal judge not to toss its suit accusing Regeneron Pharmaceuticals of paying illegal kickbacks to get doctors to prescribe its injectable eye disease drug, arguing that the biotechnology company is using a "legally irrelevant" argument.

The government shot back on Monday at Regeneron's bid to dismiss the suit, which claims the New York-based company violated the False Claims Act by funneling cash to a foundation, the Chronic Disease Fund, that reimbursed Medicare beneficiaries for copays on its drug Eylea.

The government said Regeneron is now trying to argue that it didn't know for sure...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!